Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver

Ain Shams University60 enrolled

Overview

this is a prospective, interventional, open-label, randomized study on the efficacy of omega 3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who had been selected from nutrition and outpatient clinic at Pediatric hospital, Ain Shams University

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Fatty Liver

Interventions

omega 3 fatty acidsDIETARY_SUPPLEMENT

: Life style modification, diet regimen and Omega-3 fatty acids supplementation: The dose of omega-3 fatty acids depended on the weight of patients according to World Health Organization recommendations 400 milligrams per 10 kilograms of body weight and had been given into two doses per day, before morning and evening meals

Eligibility

Sex: ALLMin age: 6 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: Children between 5 - 16 years old with diffusely hyper echogenic liver at ultrasonography were included in the study. Exclusion Criteria: * Patients with secondary causes of steatosis including total parenteral nutrition, drugs causing fatty liver disease for example steroids, hepatitis A, B, C, cytomegalovirus, Epstein-Barr virus infections, autoimmune liver disease, metabolic liver diseases, Wilson's disease, and alpha-1-antitrypsin deficiency. * Patients currently taking fish oil supplements. * Patients with systemic illness such as cardiac and kidney diseases.

Locations (1)

Pediatrics hospital Ain shams University

Cairo, Egypt

Outcomes

Primary Outcomes

grade of fatty liver in children

improvement

Time frame: 3 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.